Chamberlin, Jordan H.
Aquino, Gilberto
Nance, Sophia
Wortham, Andrew
Leaphart, Nathan
Paladugu, Namrata
Brady, Sean
Baird, Henry
Fiegel, Matthew
Fitzpatrick, Logan
Kocher, Madison
Ghesu, Florin
Mansoor, Awais
Hoelzer, Philipp
Zimmermann, Mathis
James, W. Ennis
Dennis, D. Jameson
Houston, Brian A.
Kabakus, Ismail M.
Baruah, Dhiraj
Schoepf, U. Joseph
Burt, Jeremy R.
Funding for this research was provided by:
Siemens USA
Article History
Received: 27 December 2021
Accepted: 14 July 2022
First Online: 21 July 2022
Declarations
:
: This research involved human data and was approved by the ethics committee in accordance with the Declaration of Helsinki and the authors confirm adherence to BMC journals ethics guidelines. No individual, identifiable protected health information was used for model training in this study. This study was performed by retrospective review after approval from the Medical University of South Carolina Office of Institutional Research’s institutional review board (IRB). The IRB identification number is Pro00106536. Need for informed consent for participation or publication was waived per retrospective nature of this study.
: Not applicable.
: Florin Ghesu PhD, Awais Mansoor PhD, Philipp Hoelzer PhD, Mathis Zimmermann MS MBA are employees of Seimens Healthineers. Funding: Jonathan Sperl PhD receives research funding from Siemens Healthineers. Jeremy R. Burt MD has an ownership interest in YellowDot Innovations, is a medical consultant for Canatu, and receives research funding from Siemens Healthineers. The remaining authors have no conflicts of interest to disclose.